5-Chloroimidazo[1,2-a]pyridine

Catalog No. :
ACBRQJ518
CAS No. :
63111-79-5
Molecular Formula :
C7H5ClN2
Molecular Weight :
152.58

IUPAC Name:5-chloroimidazo[1,2-a]pyridine

5-Chloroimidazo[1,2-a]pyridine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
5g98%$120.00Login to see priceIn stockInquiry
25g98%$480.00Login to see priceInquiryInquiry
100g98%$1824.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name5-Chloroimidazo[1,2-a]pyridine
IUPAC Name5-chloroimidazo[1,2-a]pyridine
MDL No.MFCD10698083
Molecular FormulaC7H5ClN2
Molecular Weight152.58
SMILESClC1=CC=CC2=NC=CN12
InChI KeyBSDNWDAKIVSEAV-UHFFFAOYSA-N
Synonym5-CHLOROIMIDAZO[1,2-A]PYRIDINE | 63111-79-5 | 5-Chloroimidazolo[1,2-a]pyridine | MFCD10698083 | SCHEMBL260187 | DTXSID40449530 | BSDNWDAKIVSEAV-UHFFFAOYSA-N | 5-chloranylimidazo[1,2-a]pyridine | 5-chloro-imidazo[1,2-alpha]pyridine | AKOS006302519 | AB61232 | AM804161 | AS-60293 |
CAS No.63111-79-5
PubChem CID10953722

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P233-P260-P261-P264-P270-P271-P280-P301+P312-P302+P352-P304-P304+P340-P305+P351+P338-P312-P321-P330-P332+P313-P337+P313-P340-P362-P403-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACBRQJ518 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACYDHF860 route compound structure diagram
    ACYDHF86045644-21-1 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACBRQJ518 route product structure diagram
    ACBRQJ51863111-79-5 In Stock
Inquiry

2. ACBRQJ518 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACBRQJ518 route product structure diagram
    ACBRQJ51863111-79-5 In Stock
Inquiry

Comments (0)